-
Describing the Amyotrophic Lateral Sclerosis US Population and Use of Supportive Aids and Interventions: Results from a Real-World Survey
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Among Ticagrelor-Treated Patients With Bleeding or Undergoing Urgent Surgery in the United States: A Real-World, Retrospective Claims Analysis
Mar 10, 2025, 14:00 PM -
The Clinical Value and Cost-Effectiveness of DefenCath for Reducing Catheter-Related Bloodstream Infections in Adult Patients Receiving Hemodialysis Through a Central Venous Catheter
Mar 10, 2025, 14:00 PM -
Predicted vs. Actual Drug Spending for Interferon-Free Direct-Acting Antiviral Therapies in Hepatitis C: A Case Study on Drug Spending Forecasts
Mar 10, 2025, 14:00 PM -
Transfusion Needs For Patients With Myelofibrosis In Latin America
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Follitropin Delta versus Follitropin Alfa in Controlled Ovarian Stimulation for IVF/ICSI Cycles in China
Mar 10, 2025, 14:00 PM -
Do Framing and Attribute Number Influence Choice Consistency in a Preference-Based Value Assessment of Equity and Efficiency?
Mar 10, 2025, 14:00 PM -
The Significance of Extracorporeal Removal Treatment in Paraquat Poisoning Patients: An Analysis of Plasma Paraquat Concentrations
Mar 10, 2025, 14:00 PM -
Global, Regional, and National Burdens of Type 1 and Type 2 Diabetes Mellitus in Adolescents from 1990 to 2021, with Forecasts to 2030: A Systematic Analysis of the Global Burden of Disease Study 2021
Mar 10, 2025, 14:00 PM -
Estimating the Magnitude of a Pull Incentive for Antibiotic Development Using the STEDI Value Framework: An Example From Spain
Mar 10, 2025, 14:00 PM -
Superior Performance of Generative AI After Application of Mixture-of-Agents LLMs in Outcomes Research
Mar 10, 2025, 14:00 PM -
Transforming Regulatory Intelligence With AI Driven Methodologies in HEOR
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Associated With Myotonic Dystrophy Type 1 With Complex Care Needs: Results From the Real-World IMPaCT Study
Mar 10, 2025, 14:00 PM -
Early Signals of Inflation Reduction Act Impact on Pharmaceutical Investment and Prioritization Decisions
Mar 10, 2025, 14:00 PM -
The Economic Burden of Narcolepsy in the United States: Matched Analysis of National Health and Wellness Survey Data
Mar 10, 2025, 14:00 PM -
Systematic Literature Review of Recombinant C1 Esterase Inhibitor (rhC1-INH) and Other Products for the On-Demand Treatment of Hereditary Angioedema Attacks
Mar 10, 2025, 14:00 PM -
The Role of Invasive Diagnostics in Prior Authorization for MASH
Mar 10, 2025, 14:00 PM -
Analysis of the Effect of Trofinetide Treatment on the Domain and Item-Level Responses of the Rett Syndrome Behavior Questionnaire Using Data From the LAVENDER Trial
Mar 10, 2025, 14:00 PM -
Examining Burden of Disease and Access to Care in Adults with X-Linked Hypophosphatemia in Brazil
Mar 10, 2025, 14:00 PM -
Economic Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D), Considering the Costs of Hospitalization Due to Heart Failure (HF) in Colombia
Mar 10, 2025, 14:00 PM
